Autopsy report · NCT00843986
Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)
Cause of deathSlow enrollment
“The clinical study has been terminated based on difficulties to enroll eligible subjects per protocol inclusion and exclusion criteria.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 4 months before it stopped.
- 9 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Cumberland Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Hyponatremia; Acute Decompensated Heart Failure
- Interventions
- conivaptan; placebo
- Participants
- 9
- Sites
- 4
- Countries
- India
Trials that died the same way
- HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer
“The clinical study was terminated due to the inability to meet target enrollment.” - Self-Management Of Asthma By Forced Oscillation Technique
“The study was terminated early due to an unexpected difficulty at the study sites in recruiting patients who met all the inclusion criteria.” - Alvimopan Use in Polytraumatized Patients
“This study was terminated due to failure to enroll, a low volume of patients met criteria.” - Virtue® Male Sling Fixation Study
“The study has been terminated due to lack of subject enrollment.” - The Effect on Mucosal Healing With Pentasa Sachet in Mild to Moderate Active "Drug: Crohn's Disease"
“Study terminated due to lack of eligible patients”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.